|
FY2026
12 months to Apr 30, 2026
|
FY2025
12 months to Apr 30, 2025
|
FY2024
12 months to Apr 30, 2024
|
FY2023
12 months to Apr 30, 2023
|
FY2022
12 months to Apr 30, 2022
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | |||||
| Stock-based compensation expense | |||||
| Depreciation and amortization expense | |||||
| Loss on sale and disposal of equipment | |||||
| Decrease in uncertain tax position | |||||
| Operating lease right-of-use assets | |||||
| Asset impairment | |||||
| Gain on termination of operating lease | |||||
| Allowance and estimated credit losses | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Prepaid expenses and other current assets | |||||
| Other long term assets | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Operating lease liabilities | |||||
| Deferred revenue | |||||
| Net cash provided by (used in) operating activities | |||||
| Investing activities: | |||||
| Purchase of property and equipment | |||||
| Proceeds from sale of equipment | |||||
| Net cash used in investing activities | |||||
| Financing activities: | |||||
| Proceeds from exercise of options | |||||
| Repurchases of common stock | |||||
| Finance lease payments | |||||
| Net cash provided by financing activities | |||||
| Increase (decrease) in cash | |||||
| Cash, beginning of year | |||||
| Cash, end of year | |||||
| Non-cash investing activities: | |||||
| Purchased equipment under finance lease | |||||
| Right-of-use assets obtained in exchange for operating lease liabilities | |||||
| Equipment purchased in accounts payable | |||||
Loading...